| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K30748066 |
| PharmacoGx | BRD-K30748066 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HCLS1 | CTRPv2 | pan-cancer | AAC | 0.43 | 0.01 |
| mRNA | LMO7DN | CTRPv2 | pan-cancer | AAC | -0.3 | 0.01 |
| mRNA | CRMP1 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.01 |
| mRNA | TRAP1 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.01 |
| mRNA | EDA | CTRPv2 | pan-cancer | AAC | 0.29 | 0.01 |
| mRNA | CLCN7 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.01 |
| mRNA | RP11-195F19.29 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.01 |
| mRNA | CAPS2 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.01 |
| mRNA | JAZF1 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.01 |
| mRNA | PYGO1 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.01 |
